+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Pharmacogenomics and Personalized Medicine · Registering as Listener

ICPHAPM
📅 4 – 5 Mar 2027 📍 Lusaka, Zambia 👥 Standard / Physical Participation
Listener Registration From
$150
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Pharmacogenomics and Personalized Medicine
ModeStandard / Physical
ParticipationListener
Registration fee$150.00
Bank charges (5.8%)$8.70
Total payable $158.70

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9

This track will explore the latest breakthroughs in pharmacogenomics, focusing on how genetic variations influence drug response. Participants will discuss novel methodologies and technologies that enhance our understanding of personalized medicine.

This session will delve into the intricate relationship between genetic variation and individual drug responses. Researchers will present findings that highlight the significance of genetic markers in therapeutic outcomes.

This track will examine the role of therapeutic genomics in developing targeted therapies. Discussions will center on integrating genomic data into clinical practice to optimize treatment strategies.

This session will focus on the identification and validation of biomarkers that can predict therapeutic efficacy. Experts will share insights on the challenges and successes in biomarker research.

This track will address the practical aspects of implementing genotype-guided therapy in clinical settings. Participants will discuss barriers to adoption and strategies for overcoming them.

This session will highlight innovative approaches in precision therapeutics, emphasizing case studies and real-world applications. Attendees will explore how precision medicine is reshaping treatment paradigms.

This track will focus on the integration of clinical genomics into routine healthcare. Discussions will cover the implications of genomic data for patient management and treatment optimization.

This session will provide an overview of current trends in pharmacogenetic testing and its impact on personalized medicine. Experts will discuss future directions and potential advancements in this field.

This track will explore the role of molecular diagnostics in enhancing pharmacogenomic applications. Participants will discuss techniques and technologies that facilitate the interpretation of genetic data.

This session will examine the intersection of targeted therapy and genomic research. Attendees will learn about the latest developments in targeted treatments informed by genomic insights.

This track will focus on the use of genomic profiling to tailor individualized treatment plans. Experts will discuss methodologies for integrating genomic information into clinical decision-making.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED